mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |